← Leaderboards
Qiuhong Li
University Of Florida
$3,933,810
Attributed
$5,829,546
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $822.4K · FY2012–25$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,829,546 · 4
By mechanism
R01$5,829,546 · 4
Top collaborators
- Michael Edwin Boulton4 shared
- Henry Daniell4 shared
- Maria B Grant4 shared
Most similar at University Of Florida
Same institution · by research overlap
- Mohan K. Raizada$21,242,274
- Michael J Katovich$2,613,563
- Christy Shawn Carter$5,191,972
- Tanya K Murphy$1,580,236
- Michael Farris Waters$1,691,339
Others in their field
Top investigators on “Renin-Angiotensin System”
- S Michael Mauer · University Of Minnesota Twin Cities$23,372,766
- Jonathan Himmelfarb · Maine Medical Center$19,069,830
- Curt Daniel Sigmund · Medical College Of Wisconsin$17,278,162
- Alessandro Doria · Joslin Diabetes Center$16,452,875
- Dan M Roden · Vanderbilt University Medical Center$13,619,422
- Michal Laniado Schwartzman · New York Medical College$13,259,109
Research focus
Renin-Angiotensin SystemMediatingDiabetes MellitusReceptorRetinaFunctional DisorderDiabetic RetinopathyDiabeticAngiotensin IiAnimal ModelPeptidyl-Dipeptidase APreventPathogenesisOxidative StressPathologicInflammatoryCellsMaintenanceInflammationEquilibriumEnzymesPathologyTissuesHyperactive Behavior
Grant awards (15)
Pro/renin receptor-mediated signaling in pathogenesis of diabetic retinopathy$381,250
R01 · FY2025 · EY · contact PI
Pro/renin receptor-mediated signaling in pathogenesis of diabetic retinopathy$381,250
R01 · FY2024 · EY · contact PI
Pro/renin receptor-mediated signaling in pathogenesis of diabetic retinopathy$381,250
R01 · FY2023 · EY · contact PI
ACE2 Modulates the Bone Marrow- Gut Axis in Diabetic Retinopathy$391,180
R01 · FY2021 · EY
ACE2 Modulates the Bone Marrow- Gut Axis in Diabetic Retinopathy$403,279
R01 · FY2020 · EY
ACE2 Modulates the Bone Marrow- Gut Axis in Diabetic Retinopathy$403,279
R01 · FY2019 · EY
ACE2 Modulates the Bone Marrow- Gut Axis in Diabetic Retinopathy$415,404
R01 · FY2018 · EY
Oral therapy for diabetic retinopathy using ACE2/Ang1-7 bioencapsulated in plant cells$407,029
R01 · FY2018 · EY · contact PI
Oral therapy for diabetic retinopathy using ACE2/Ang1-7 bioencapsulated in plant cells$407,029
R01 · FY2017 · EY · contact PI
Oral therapy for diabetic retinopathy using ACE2/Ang1-7 bioencapsulated in plant cells$407,029
R01 · FY2016 · EY · contact PI
Oral therapy for diabetic retinopathy using ACE2/Ang1-7 bioencapsulated in plant cells$419,529
R01 · FY2015 · EY · contact PI
Ocular Renin Angiotensin System in Pathogenesis of Diabetic Retinopathy$358,925
R01 · FY2015 · EY · contact PI
Ocular Renin Angiotensin System in Pathogenesis of Diabetic Retinopathy$358,925
R01 · FY2014 · EY · contact PI
Ocular Renin Angiotensin System in Pathogenesis of Diabetic Retinopathy$347,938
R01 · FY2013 · EY · contact PI
Ocular Renin Angiotensin System in Pathogenesis of Diabetic Retinopathy$366,250
R01 · FY2012 · EY · contact PI